Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117510306A reveals a novel 3-Phenanthrol synthesis route. Achieve higher purity without chromatography. Reliable supply chain for pharmaceutical intermediates.
Patent CN116003326A details a novel Rh-catalyzed one-pot synthesis of trifluoromethyl indazoles. This method offers mild conditions, broad substrate scope, and significant cost reduction in API manufacturing.
Patent CN101314559B details a low-cost kinetic resolution method for aromatic chiral secondary alcohols using Boc-Proline, offering high purity for pharma intermediates.
Novel cycloisomerization method for high-purity deuterated chromone intermediates. Offers improved yield and deuteration rates for pharmaceutical applications.
Novel Wittig reaction route ensures high purity impurity standard for Rosuvastatin Calcium quality control and regulatory compliance supply chain.
Novel nickel-catalyzed oxidation route for Acalabrutinib key intermediate reduces cost and pollution while ensuring high purity for pharma supply chains.
Patent CN108299401B discloses a high-yield synthesis of 3-benzyl coumarin-imidazole salts. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel microwave-assisted method for trans-stilbene intermediates reduces costs and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN108424380A enables efficient copper-catalyzed synthesis. Reduces manufacturing costs and ensures supply continuity for high-purity pharmaceutical intermediates.
Patent CN110551037B details a high-efficiency iridium/chiral diphosphine system for asymmetric hydrogenation, offering superior enantioselectivity for agrochemical intermediates.
Advanced convergent synthesis for Gefitinib intermediates eliminating chromatography. High-purity API manufacturing solutions for global pharmaceutical supply chains.
Patent CN110590823A reveals non-transition metal catalysis for borate derivatives. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN114874153B reveals metal-free oxidative cyclization for naphtho[2,1-d]oxazoles. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN121380982A enables metal-free electrochemical production of high-purity anti-tumor intermediates with significant supply chain and cost advantages for pharmaceutical manufacturers.
Novel metal-free asymmetric deuteration method using D2O. High enantioselectivity for pharma intermediates. Cost-effective supply chain solution.
Patent CN103497082B reveals solvent-free beta-nitrostyrene synthesis using reusable acidic ionic liquids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel scalable route for 4-(1-cyclopropyl-1H-indol-3-yl) derivatives. High purity, optimized cyclopropylation for third-generation EGFR inhibitors.
Patent CN101906061B reveals a green water-phase catalytic method for indole synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN118125939B reveals metal-free diamination. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable high-purity processes.
Novel iridium-catalyzed C-H bond boronation method offers high selectivity and yield for pharmaceutical intermediate manufacturing without strong acids.